← Back to Search

Cell Therapy

PSC-01 for Osteoarthritis

Phase 1
Waitlist Available
Research Sponsored by Personalized Stem Cells, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-4 months
Awards & highlights

Summary

The objective of this clinical study is to evaluate the safety of an intraarticular injection of an investigational biologic product (IBP), PSC-01, the patient's own adipose-derived stromal vascular fraction cells (SVF) extracted from a lipoaspirate sample, to treat the pain of osteoarthritis in a single knee. The secondary objective is to get initial data on efficacy of the PSC-01.

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of Adverse Events
Secondary study objectives
Changes in KOOS Measurement

Trial Design

1Treatment groups
Experimental Treatment
Group I: PSC-01Experimental Treatment1 Intervention
All study participants will receive intraarticular injection of the investigational biological product, PSC-01.

Find a Location

Who is running the clinical trial?

Personalized Stem Cells, Inc.Lead Sponsor
~21 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top